Fjarde AP Fonden Fourth Swedish National Pension Fund Has $2.59 Million Stake in DENTSPLY SIRONA Inc (XRAY)

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 27.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 52,293 shares of the medical instruments supplier’s stock after buying an additional 11,340 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in DENTSPLY SIRONA were worth $2,593,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in XRAY. Advisor Partners LLC acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth about $367,000. S&CO Inc. raised its stake in DENTSPLY SIRONA by 4.3% in the 1st quarter. S&CO Inc. now owns 57,040 shares of the medical instruments supplier’s stock worth $2,829,000 after purchasing an additional 2,352 shares in the last quarter. Natixis Advisors L.P. raised its position in shares of DENTSPLY SIRONA by 30.7% in the 4th quarter. Natixis Advisors L.P. now owns 44,911 shares of the medical instruments supplier’s stock valued at $1,671,000 after buying an additional 10,547 shares in the last quarter. Stone Ridge Asset Management LLC raised its position in shares of DENTSPLY SIRONA by 50.8% in the 4th quarter. Stone Ridge Asset Management LLC now owns 29,170 shares of the medical instruments supplier’s stock valued at $1,085,000 after buying an additional 9,825 shares in the last quarter. Finally, AMG National Trust Bank acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $1,379,000. 91.69% of the stock is owned by institutional investors and hedge funds.

Shares of DENTSPLY SIRONA stock traded up $0.06 during midday trading on Wednesday, hitting $53.72. 2,088,498 shares of the company traded hands, compared to its average volume of 1,869,180. The firm has a market capitalization of $12.58 billion, a PE ratio of 26.73, a price-to-earnings-growth ratio of 2.00 and a beta of 1.11. The company has a current ratio of 2.06, a quick ratio of 1.35 and a debt-to-equity ratio of 0.33. DENTSPLY SIRONA Inc has a 12 month low of $33.93 and a 12 month high of $55.88.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The company had revenue of $946.20 million for the quarter, compared to analyst estimates of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The firm’s revenue was down 1.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.45 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc will post 2.34 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be issued a dividend of $0.0875 per share. The ex-dividend date is Thursday, June 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. DENTSPLY SIRONA’s payout ratio is 17.41%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 9,160 shares of the business’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $53.45, for a total transaction of $489,602.00. Following the sale, the director now directly owns 26,003 shares of the company’s stock, valued at approximately $1,389,860.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Daniel P. Key bought 3,697 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, May 7th. The shares were acquired at an average cost of $54.68 per share, for a total transaction of $202,151.96. Following the completion of the acquisition, the senior vice president now directly owns 9,024 shares in the company, valued at $493,432.32. The disclosure for this purchase can be found here. Insiders have sold a total of 123,922 shares of company stock worth $6,790,905 over the last ninety days. 0.62% of the stock is currently owned by insiders.

Several equities analysts have recently commented on XRAY shares. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 target price for the company in a research report on Saturday, March 9th. Bank of America started coverage on shares of DENTSPLY SIRONA in a research report on Monday, March 18th. They issued a “buy” rating and a $57.00 target price for the company. BidaskClub cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 23rd. ValuEngine upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Finally, HC Wainwright set a $49.00 target price on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research report on Friday, April 5th. Nine research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $53.62.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://sundanceherald.com/2019/05/29/fjarde-ap-fonden-fourth-swedish-national-pension-fund-acquires-11340-shares-of-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: Marijuana Stocks

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply